Skip to main content


Media Coverage

US Antitrust Enforcers Could Undo Valeant Lens Monopoly-Lawyers

3 November 2015
Litigation & Dispute Resolution partner Bill Stallings (Washington DC) is quoted in this article discussing actions the FTC could take against Valeant Pharmaceuticals International Inc.
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.